Austin Larson
Concepts (355)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Neurodevelopmental Disorders | 12 | 2024 | 239 | 2.010 |
Why?
| | Intellectual Disability | 8 | 2024 | 183 | 1.750 |
Why?
| | Congenital Disorders of Glycosylation | 9 | 2026 | 19 | 1.650 |
Why?
| | Abnormalities, Multiple | 7 | 2024 | 195 | 1.380 |
Why?
| | Mutation | 18 | 2026 | 4093 | 1.130 |
Why?
| | Phenotype | 24 | 2026 | 3206 | 0.970 |
Why?
| | Bone Diseases, Developmental | 2 | 2024 | 17 | 0.900 |
Why?
| | Mitochondrial Diseases | 5 | 2026 | 94 | 0.890 |
Why?
| | Pyruvate Dehydrogenase Complex Deficiency Disease | 2 | 2026 | 7 | 0.850 |
Why?
| | Mitochondrial Encephalomyopathies | 2 | 2020 | 8 | 0.780 |
Why?
| | Mitochondria | 7 | 2026 | 997 | 0.780 |
Why?
| | Mitochondrial Proton-Translocating ATPases | 2 | 2020 | 23 | 0.690 |
Why?
| | Diet, Ketogenic | 3 | 2021 | 40 | 0.670 |
Why?
| | Xanthomatosis, Cerebrotendinous | 3 | 2025 | 5 | 0.630 |
Why?
| | Thymidine Phosphorylase | 1 | 2020 | 13 | 0.620 |
Why?
| | Gray Matter | 1 | 2019 | 96 | 0.560 |
Why?
| | Dystroglycans | 1 | 2018 | 5 | 0.550 |
Why?
| | Qb-SNARE Proteins | 1 | 2018 | 7 | 0.550 |
Why?
| | Muscular Dystrophies | 1 | 2018 | 29 | 0.540 |
Why?
| | Infant | 25 | 2025 | 10114 | 0.540 |
Why?
| | Multiple Carboxylase Deficiency | 1 | 2018 | 1 | 0.540 |
Why?
| | Vesicular Transport Proteins | 1 | 2018 | 85 | 0.520 |
Why?
| | Glycosylation | 9 | 2026 | 177 | 0.510 |
Why?
| | Phosphotransferases (Phosphomutases) | 4 | 2025 | 6 | 0.500 |
Why?
| | Child, Preschool | 25 | 2026 | 11913 | 0.450 |
Why?
| | Acidosis, Lactic | 3 | 2024 | 46 | 0.450 |
Why?
| | Hypopituitarism | 1 | 2015 | 16 | 0.440 |
Why?
| | Mitochondrial Proteins | 3 | 2026 | 263 | 0.440 |
Why?
| | Cardiomyopathies | 3 | 2024 | 340 | 0.430 |
Why?
| | Developmental Disabilities | 3 | 2024 | 281 | 0.420 |
Why?
| | Adrenal Insufficiency | 3 | 2021 | 31 | 0.420 |
Why?
| | Genetic Association Studies | 5 | 2025 | 379 | 0.400 |
Why?
| | Seizures | 5 | 2023 | 489 | 0.400 |
Why?
| | Prilocaine | 1 | 2013 | 5 | 0.380 |
Why?
| | Humans | 69 | 2026 | 146342 | 0.380 |
Why?
| | Methemoglobinemia | 1 | 2013 | 13 | 0.380 |
Why?
| | Cephalometry | 1 | 2013 | 30 | 0.380 |
Why?
| | Dystocia | 1 | 2013 | 12 | 0.380 |
Why?
| | Liver Transplantation | 1 | 2020 | 751 | 0.380 |
Why?
| | Sexual Development | 1 | 2012 | 17 | 0.370 |
Why?
| | Female | 46 | 2026 | 79499 | 0.370 |
Why?
| | Lidocaine | 1 | 2013 | 55 | 0.370 |
Why?
| | Fetal Macrosomia | 1 | 2013 | 64 | 0.370 |
Why?
| | Magnetic Resonance Imaging | 6 | 2020 | 3926 | 0.370 |
Why?
| | Shoulder | 1 | 2013 | 105 | 0.360 |
Why?
| | Child | 31 | 2026 | 22693 | 0.360 |
Why?
| | Anesthetics, Local | 1 | 2013 | 106 | 0.350 |
Why?
| | Membrane Transport Proteins | 2 | 2026 | 154 | 0.350 |
Why?
| | Male | 43 | 2026 | 73396 | 0.340 |
Why?
| | Carnitine | 2 | 2025 | 91 | 0.340 |
Why?
| | DNA, Mitochondrial | 2 | 2024 | 212 | 0.340 |
Why?
| | Adolescent | 21 | 2026 | 22557 | 0.330 |
Why?
| | Infant, Newborn | 12 | 2026 | 6460 | 0.310 |
Why?
| | Heterozygote | 6 | 2024 | 311 | 0.290 |
Why?
| | Chenodeoxycholic Acid | 2 | 2025 | 11 | 0.280 |
Why?
| | Cholestanol | 2 | 2025 | 4 | 0.260 |
Why?
| | Transcription Factors | 4 | 2022 | 1730 | 0.260 |
Why?
| | Intestinal Pseudo-Obstruction | 2 | 2019 | 8 | 0.260 |
Why?
| | Epilepsy | 3 | 2023 | 400 | 0.260 |
Why?
| | Genetic Testing | 4 | 2023 | 492 | 0.260 |
Why?
| | Genetic Variation | 3 | 2021 | 996 | 0.250 |
Why?
| | Biomarkers | 8 | 2026 | 4340 | 0.250 |
Why?
| | Nerve Tissue Proteins | 2 | 2021 | 597 | 0.250 |
Why?
| | Fibroblasts | 6 | 2026 | 1034 | 0.240 |
Why?
| | Genetic Predisposition to Disease | 4 | 2019 | 2488 | 0.240 |
Why?
| | Epidermolysis Bullosa Simplex | 1 | 2026 | 10 | 0.240 |
Why?
| | Photophobia | 1 | 2026 | 13 | 0.230 |
Why?
| | Fucose | 1 | 2026 | 7 | 0.230 |
Why?
| | Ichthyosis | 1 | 2026 | 8 | 0.230 |
Why?
| | Alopecia | 1 | 2026 | 33 | 0.230 |
Why?
| | MELAS Syndrome | 1 | 2025 | 5 | 0.230 |
Why?
| | Monosaccharide Transport Proteins | 1 | 2026 | 55 | 0.230 |
Why?
| | Nuclear Proteins | 2 | 2022 | 740 | 0.230 |
Why?
| | Receptors, Virus | 1 | 2026 | 91 | 0.230 |
Why?
| | Rhodanine | 2 | 2023 | 2 | 0.220 |
Why?
| | Thiazolidines | 2 | 2023 | 13 | 0.220 |
Why?
| | Enoyl-CoA Hydratase | 1 | 2025 | 12 | 0.220 |
Why?
| | Carrier Proteins | 2 | 2019 | 728 | 0.220 |
Why?
| | Autism Spectrum Disorder | 2 | 2021 | 406 | 0.220 |
Why?
| | Young Adult | 13 | 2026 | 14330 | 0.220 |
Why?
| | Collagen Type VII | 1 | 2025 | 25 | 0.220 |
Why?
| | Nervous System Malformations | 2 | 2022 | 47 | 0.210 |
Why?
| | Dichloroacetic Acid | 1 | 2024 | 7 | 0.210 |
Why?
| | Actins | 2 | 2019 | 422 | 0.210 |
Why?
| | Zebrafish | 3 | 2026 | 536 | 0.210 |
Why?
| | Epidermolysis Bullosa Dystrophica | 1 | 2025 | 40 | 0.210 |
Why?
| | Growth Differentiation Factor 15 | 1 | 2024 | 44 | 0.210 |
Why?
| | Metabolism, Inborn Errors | 2 | 2021 | 42 | 0.210 |
Why?
| | Bezafibrate | 1 | 2024 | 10 | 0.210 |
Why?
| | Acyl-CoA Dehydrogenases | 1 | 2024 | 12 | 0.210 |
Why?
| | Loss of Function Mutation | 2 | 2021 | 48 | 0.210 |
Why?
| | Pyridinium Compounds | 1 | 2024 | 31 | 0.210 |
Why?
| | Sotos Syndrome | 1 | 2024 | 2 | 0.200 |
Why?
| | Septo-Optic Dysplasia | 1 | 2024 | 5 | 0.200 |
Why?
| | Adult | 20 | 2026 | 41087 | 0.200 |
Why?
| | Megalencephaly | 1 | 2024 | 20 | 0.200 |
Why?
| | Chromosome Disorders | 1 | 2023 | 46 | 0.190 |
Why?
| | Aldehyde Reductase | 1 | 2023 | 31 | 0.190 |
Why?
| | Niacinamide | 1 | 2024 | 103 | 0.190 |
Why?
| | Craniofacial Abnormalities | 1 | 2024 | 78 | 0.190 |
Why?
| | Autistic Disorder | 2 | 2023 | 216 | 0.190 |
Why?
| | Chromosome Deletion | 2 | 2023 | 127 | 0.190 |
Why?
| | Bile Acids and Salts | 1 | 2024 | 163 | 0.190 |
Why?
| | Hematologic Diseases | 1 | 2023 | 66 | 0.180 |
Why?
| | Cerebellar Diseases | 1 | 2022 | 27 | 0.180 |
Why?
| | De Lange Syndrome | 1 | 2022 | 2 | 0.180 |
Why?
| | Phosphoproteins | 2 | 2021 | 320 | 0.180 |
Why?
| | Vestibular Diseases | 1 | 2023 | 45 | 0.180 |
Why?
| | RNA, Transfer | 2 | 2020 | 142 | 0.180 |
Why?
| | Amino Acid Substitution | 2 | 2020 | 297 | 0.180 |
Why?
| | Transposases | 1 | 2022 | 18 | 0.180 |
Why?
| | Sorbitol | 1 | 2021 | 13 | 0.170 |
Why?
| | Dwarfism | 1 | 2021 | 15 | 0.170 |
Why?
| | High-Throughput Nucleotide Sequencing | 4 | 2020 | 539 | 0.170 |
Why?
| | Wolf-Hirschhorn Syndrome | 1 | 2021 | 2 | 0.170 |
Why?
| | Metabolism | 1 | 2021 | 44 | 0.170 |
Why?
| | Methionine | 1 | 2021 | 160 | 0.160 |
Why?
| | Vitamin B 12 | 1 | 2021 | 140 | 0.160 |
Why?
| | Chromosomal Proteins, Non-Histone | 1 | 2021 | 131 | 0.160 |
Why?
| | Nuclear Receptor Subfamily 4, Group A, Member 2 | 1 | 2020 | 8 | 0.160 |
Why?
| | Receptors, CCR4 | 1 | 2020 | 22 | 0.160 |
Why?
| | Aldehyde-Lyases | 1 | 2020 | 3 | 0.160 |
Why?
| | Drosophila Proteins | 1 | 2022 | 207 | 0.160 |
Why?
| | Nephrosis | 1 | 2020 | 6 | 0.160 |
Why?
| | Vitamin B 6 | 1 | 2020 | 11 | 0.160 |
Why?
| | Prenatal Care | 1 | 2023 | 310 | 0.160 |
Why?
| | Adrenal Hyperplasia, Congenital | 1 | 2021 | 39 | 0.160 |
Why?
| | N-Acetylglucosaminyltransferases | 1 | 2020 | 25 | 0.160 |
Why?
| | Neurodegenerative Diseases | 1 | 2022 | 147 | 0.160 |
Why?
| | Quinone Reductases | 1 | 2020 | 12 | 0.160 |
Why?
| | Dietary Supplements | 2 | 2026 | 587 | 0.160 |
Why?
| | Mucolipidoses | 1 | 2020 | 9 | 0.160 |
Why?
| | Myotonin-Protein Kinase | 1 | 2020 | 2 | 0.160 |
Why?
| | Sequence Analysis, DNA | 2 | 2020 | 771 | 0.160 |
Why?
| | Leigh Disease | 1 | 2020 | 22 | 0.160 |
Why?
| | Oxidoreductases Acting on Sulfur Group Donors | 1 | 2020 | 14 | 0.160 |
Why?
| | Thymidine | 1 | 2020 | 57 | 0.160 |
Why?
| | ATP-Dependent Proteases | 1 | 2020 | 2 | 0.160 |
Why?
| | Multiple Acyl Coenzyme A Dehydrogenase Deficiency | 1 | 2020 | 2 | 0.150 |
Why?
| | Liver Cirrhosis | 1 | 2022 | 278 | 0.150 |
Why?
| | Muscular Diseases | 1 | 2020 | 110 | 0.150 |
Why?
| | Lymphopenia | 1 | 2020 | 62 | 0.150 |
Why?
| | Tyrosine | 1 | 2020 | 217 | 0.150 |
Why?
| | Tumor Suppressor Proteins | 1 | 2022 | 315 | 0.150 |
Why?
| | Neuronal Ceroid-Lipofuscinoses | 1 | 2019 | 5 | 0.150 |
Why?
| | Membrane Proteins | 2 | 2023 | 1130 | 0.150 |
Why?
| | Esophageal Motility Disorders | 1 | 2020 | 28 | 0.150 |
Why?
| | Energy Metabolism | 1 | 2026 | 930 | 0.150 |
Why?
| | Hydrogen Sulfide | 1 | 2020 | 47 | 0.150 |
Why?
| | Mutagenesis, Insertional | 1 | 2019 | 68 | 0.150 |
Why?
| | Albinism | 1 | 2019 | 3 | 0.150 |
Why?
| | Lysosomal Storage Diseases | 1 | 2019 | 5 | 0.150 |
Why?
| | Acids | 1 | 2019 | 17 | 0.150 |
Why?
| | Retrospective Studies | 8 | 2026 | 17438 | 0.150 |
Why?
| | HEK293 Cells | 1 | 2022 | 750 | 0.150 |
Why?
| | Histone-Lysine N-Methyltransferase | 1 | 2021 | 141 | 0.150 |
Why?
| | Chloride Channels | 1 | 2019 | 33 | 0.150 |
Why?
| | Proteolysis | 1 | 2020 | 174 | 0.140 |
Why?
| | Oligonucleotides, Antisense | 1 | 2019 | 122 | 0.140 |
Why?
| | Chromosomes, Human, Pair 17 | 1 | 2018 | 54 | 0.140 |
Why?
| | Galactosyltransferases | 1 | 2018 | 12 | 0.140 |
Why?
| | Leukoencephalopathies | 1 | 2018 | 23 | 0.140 |
Why?
| | Peripheral Nervous System Diseases | 1 | 2020 | 135 | 0.140 |
Why?
| | Rare Diseases | 1 | 2019 | 117 | 0.140 |
Why?
| | Scoliosis | 1 | 2021 | 231 | 0.140 |
Why?
| | Ehlers-Danlos Syndrome | 1 | 2018 | 16 | 0.140 |
Why?
| | Bronchiectasis | 1 | 2020 | 115 | 0.140 |
Why?
| | Lysosomes | 1 | 2019 | 134 | 0.140 |
Why?
| | Spasms, Infantile | 1 | 2020 | 138 | 0.140 |
Why?
| | Fetus | 1 | 2023 | 800 | 0.140 |
Why?
| | Arginine | 1 | 2019 | 264 | 0.140 |
Why?
| | Gene Expression | 2 | 2020 | 1463 | 0.130 |
Why?
| | Alkyl and Aryl Transferases | 1 | 2018 | 31 | 0.130 |
Why?
| | Metalloendopeptidases | 1 | 2018 | 63 | 0.130 |
Why?
| | Nerve Degeneration | 1 | 2018 | 48 | 0.130 |
Why?
| | Trachea | 1 | 2020 | 253 | 0.130 |
Why?
| | Ubiquinone | 1 | 2018 | 36 | 0.130 |
Why?
| | Enzyme Inhibitors | 1 | 2021 | 823 | 0.130 |
Why?
| | Molecular Chaperones | 1 | 2020 | 200 | 0.130 |
Why?
| | Phenylalanine-tRNA Ligase | 1 | 2017 | 2 | 0.130 |
Why?
| | Ataxia | 1 | 2018 | 69 | 0.130 |
Why?
| | Nephrotic Syndrome | 1 | 2018 | 44 | 0.130 |
Why?
| | Spastic Paraplegia, Hereditary | 1 | 2017 | 13 | 0.130 |
Why?
| | Cohort Studies | 4 | 2026 | 6077 | 0.130 |
Why?
| | Muscle Weakness | 1 | 2018 | 93 | 0.130 |
Why?
| | Catalytic Domain | 1 | 2018 | 235 | 0.130 |
Why?
| | Hematopoietic Stem Cell Transplantation | 2 | 2020 | 704 | 0.120 |
Why?
| | Cellular Senescence | 1 | 2019 | 225 | 0.120 |
Why?
| | Diffusion Magnetic Resonance Imaging | 1 | 2018 | 158 | 0.120 |
Why?
| | Urinary Bladder | 2 | 2019 | 194 | 0.120 |
Why?
| | Colon | 2 | 2019 | 304 | 0.120 |
Why?
| | Diabetes Insipidus | 1 | 2015 | 6 | 0.110 |
Why?
| | Holoprosencephaly | 1 | 2015 | 8 | 0.110 |
Why?
| | Pregnancy | 5 | 2023 | 7230 | 0.110 |
Why?
| | Precision Medicine | 1 | 2019 | 462 | 0.110 |
Why?
| | Cholestanetriol 26-Monooxygenase | 2 | 2025 | 7 | 0.110 |
Why?
| | Human Growth Hormone | 1 | 2015 | 46 | 0.110 |
Why?
| | Thyrotropin | 1 | 2015 | 120 | 0.110 |
Why?
| | Hypogonadism | 1 | 2015 | 89 | 0.100 |
Why?
| | Brain | 4 | 2020 | 2991 | 0.100 |
Why?
| | Muscle, Skeletal | 3 | 2020 | 1818 | 0.100 |
Why?
| | Histones | 1 | 2019 | 670 | 0.100 |
Why?
| | Introns | 2 | 2025 | 257 | 0.100 |
Why?
| | RNA | 1 | 2020 | 926 | 0.100 |
Why?
| | Mutation, Missense | 3 | 2021 | 334 | 0.100 |
Why?
| | Cephalopelvic Disproportion | 1 | 2013 | 2 | 0.100 |
Why?
| | Vacuum Extraction, Obstetrical | 1 | 2013 | 4 | 0.100 |
Why?
| | Port-Wine Stain | 1 | 2013 | 4 | 0.100 |
Why?
| | Rhode Island | 1 | 2013 | 30 | 0.100 |
Why?
| | Quality of Life | 1 | 2025 | 3200 | 0.090 |
Why?
| | Brachial Plexus | 1 | 2013 | 34 | 0.090 |
Why?
| | WT1 Proteins | 1 | 2012 | 12 | 0.090 |
Why?
| | Administration, Topical | 1 | 2013 | 154 | 0.090 |
Why?
| | Polymorphism, Single Nucleotide | 1 | 2020 | 2240 | 0.090 |
Why?
| | SOX9 Transcription Factor | 1 | 2012 | 27 | 0.090 |
Why?
| | Homozygote | 2 | 2025 | 197 | 0.090 |
Why?
| | RNA Splicing Factors | 1 | 2012 | 66 | 0.090 |
Why?
| | Middle Aged | 8 | 2026 | 36619 | 0.090 |
Why?
| | Drosophila | 2 | 2023 | 168 | 0.080 |
Why?
| | Pedigree | 2 | 2026 | 512 | 0.080 |
Why?
| | DNA-Binding Proteins | 2 | 2022 | 1468 | 0.080 |
Why?
| | Case-Control Studies | 2 | 2022 | 3647 | 0.080 |
Why?
| | Electron Transport Complex IV | 2 | 2020 | 61 | 0.080 |
Why?
| | Syndrome | 2 | 2022 | 380 | 0.080 |
Why?
| | Alleles | 2 | 2026 | 907 | 0.080 |
Why?
| | Haploinsufficiency | 2 | 2020 | 53 | 0.080 |
Why?
| | Urban Population | 1 | 2013 | 497 | 0.080 |
Why?
| | DNA Mutational Analysis | 2 | 2021 | 410 | 0.070 |
Why?
| | Oxidative Phosphorylation | 2 | 2020 | 212 | 0.070 |
Why?
| | Diabetes, Gestational | 1 | 2013 | 307 | 0.070 |
Why?
| | Electron Transport | 2 | 2020 | 110 | 0.070 |
Why?
| | Diagnosis, Differential | 1 | 2013 | 1503 | 0.070 |
Why?
| | Skin | 2 | 2026 | 701 | 0.070 |
Why?
| | Genotype | 2 | 2026 | 1879 | 0.070 |
Why?
| | Cell Cycle Proteins | 2 | 2022 | 630 | 0.070 |
Why?
| | Prospective Studies | 3 | 2025 | 8123 | 0.060 |
Why?
| | Gene Expression Regulation, Developmental | 1 | 2012 | 902 | 0.060 |
Why?
| | Proteomics | 2 | 2024 | 1203 | 0.060 |
Why?
| | Mitochondrial Myopathies | 1 | 2026 | 10 | 0.060 |
Why?
| | Genetic Counseling | 1 | 2026 | 82 | 0.060 |
Why?
| | Animals | 6 | 2026 | 38107 | 0.060 |
Why?
| | Genes, Dominant | 1 | 2026 | 95 | 0.060 |
Why?
| | Neuropsychological Tests | 2 | 2021 | 1149 | 0.060 |
Why?
| | Cholestenones | 1 | 2025 | 1 | 0.060 |
Why?
| | Biopsy | 2 | 2019 | 1075 | 0.060 |
Why?
| | Pyruvate Dehydrogenase (Lipoamide) | 1 | 2024 | 10 | 0.050 |
Why?
| | Genes, Recessive | 1 | 2025 | 77 | 0.050 |
Why?
| | Exome | 2 | 2017 | 233 | 0.050 |
Why?
| | DNA Helicases | 1 | 2026 | 138 | 0.050 |
Why?
| | Cholestanols | 1 | 2024 | 1 | 0.050 |
Why?
| | NFI Transcription Factors | 1 | 2024 | 7 | 0.050 |
Why?
| | Dried Blood Spot Testing | 1 | 2025 | 129 | 0.050 |
Why?
| | Age of Onset | 1 | 2026 | 558 | 0.050 |
Why?
| | Aged | 4 | 2026 | 26432 | 0.050 |
Why?
| | Chromosomes, Human, Pair 16 | 1 | 2023 | 36 | 0.050 |
Why?
| | Carboxylic Ester Hydrolases | 1 | 2023 | 24 | 0.050 |
Why?
| | Mannose | 1 | 2023 | 23 | 0.050 |
Why?
| | Tertiary Care Centers | 1 | 2024 | 196 | 0.050 |
Why?
| | Goals | 1 | 2025 | 187 | 0.050 |
Why?
| | Fatigue | 1 | 2025 | 363 | 0.050 |
Why?
| | Drug Combinations | 1 | 2024 | 400 | 0.050 |
Why?
| | Histone Demethylases | 1 | 2023 | 39 | 0.050 |
Why?
| | RNA, Messenger | 2 | 2022 | 2791 | 0.050 |
Why?
| | Cross-Sectional Studies | 2 | 2025 | 5899 | 0.050 |
Why?
| | Cross-Over Studies | 1 | 2025 | 615 | 0.050 |
Why?
| | Cause of Death | 1 | 2025 | 456 | 0.050 |
Why?
| | Exons | 1 | 2024 | 361 | 0.050 |
Why?
| | 5-Methyltetrahydrofolate-Homocysteine S-Methyltransferase | 1 | 2021 | 18 | 0.040 |
Why?
| | Muscle Hypotonia | 1 | 2021 | 34 | 0.040 |
Why?
| | Amino Acid Metabolism, Inborn Errors | 1 | 2021 | 25 | 0.040 |
Why?
| | Language Development Disorders | 1 | 2021 | 40 | 0.040 |
Why?
| | Patient Acuity | 1 | 2021 | 46 | 0.040 |
Why?
| | Interviews as Topic | 1 | 2025 | 930 | 0.040 |
Why?
| | Workflow | 1 | 2023 | 182 | 0.040 |
Why?
| | Neuroglia | 1 | 2022 | 177 | 0.040 |
Why?
| | Face | 1 | 2023 | 177 | 0.040 |
Why?
| | Sequence Analysis, RNA | 1 | 2024 | 441 | 0.040 |
Why?
| | Receptors, Cell Surface | 1 | 2023 | 371 | 0.040 |
Why?
| | Hepatocytes | 1 | 2022 | 224 | 0.040 |
Why?
| | Homocysteine | 1 | 2021 | 152 | 0.040 |
Why?
| | Echocardiography | 1 | 2024 | 645 | 0.040 |
Why?
| | Methylation | 1 | 2021 | 241 | 0.040 |
Why?
| | Transferrin | 1 | 2020 | 48 | 0.040 |
Why?
| | Early Diagnosis | 1 | 2021 | 251 | 0.040 |
Why?
| | Patient Reported Outcome Measures | 1 | 2025 | 516 | 0.040 |
Why?
| | Administration, Intravenous | 1 | 2021 | 172 | 0.040 |
Why?
| | Acyl-CoA Dehydrogenase | 1 | 2020 | 8 | 0.040 |
Why?
| | Frameshift Mutation | 1 | 2020 | 32 | 0.040 |
Why?
| | 3-Hydroxybutyric Acid | 1 | 2020 | 17 | 0.040 |
Why?
| | Double-Blind Method | 1 | 2025 | 2070 | 0.040 |
Why?
| | Sensitivity and Specificity | 1 | 2024 | 1998 | 0.040 |
Why?
| | Facies | 1 | 2019 | 22 | 0.040 |
Why?
| | Cell Nucleolus | 1 | 2019 | 21 | 0.040 |
Why?
| | Protein Stability | 1 | 2020 | 180 | 0.040 |
Why?
| | Vitamins | 1 | 2021 | 183 | 0.040 |
Why?
| | Drugs, Investigational | 1 | 2019 | 31 | 0.040 |
Why?
| | Cognitive Dysfunction | 1 | 2025 | 481 | 0.040 |
Why?
| | Feeding and Eating Disorders | 1 | 2021 | 162 | 0.040 |
Why?
| | Heme | 1 | 2020 | 90 | 0.040 |
Why?
| | Phosphates | 1 | 2020 | 175 | 0.040 |
Why?
| | Xenopus laevis | 1 | 2019 | 101 | 0.040 |
Why?
| | Repressor Proteins | 1 | 2022 | 430 | 0.040 |
Why?
| | 14-3-3 Proteins | 1 | 2018 | 15 | 0.040 |
Why?
| | Molecular Diagnostic Techniques | 1 | 2019 | 104 | 0.040 |
Why?
| | Leukemia | 1 | 2021 | 246 | 0.040 |
Why?
| | 1-Alkyl-2-acetylglycerophosphocholine Esterase | 1 | 2018 | 24 | 0.040 |
Why?
| | Aneuploidy | 1 | 2019 | 88 | 0.040 |
Why?
| | Bronchoscopy | 1 | 2020 | 227 | 0.040 |
Why?
| | Enzyme Assays | 1 | 2018 | 25 | 0.040 |
Why?
| | Brain Diseases | 1 | 2020 | 159 | 0.030 |
Why?
| | Nutritional Status | 1 | 2021 | 346 | 0.030 |
Why?
| | Risk Factors | 1 | 2013 | 10921 | 0.030 |
Why?
| | Drug Discovery | 1 | 2019 | 154 | 0.030 |
Why?
| | Whole Genome Sequencing | 1 | 2019 | 183 | 0.030 |
Why?
| | Dermis | 1 | 2018 | 31 | 0.030 |
Why?
| | Oocytes | 1 | 2019 | 186 | 0.030 |
Why?
| | Critical Illness | 1 | 2024 | 908 | 0.030 |
Why?
| | Weight Gain | 1 | 2021 | 562 | 0.030 |
Why?
| | Hydrogen-Ion Concentration | 1 | 2019 | 534 | 0.030 |
Why?
| | Aminoacylation | 1 | 2017 | 14 | 0.030 |
Why?
| | Microtubule-Associated Proteins | 1 | 2018 | 187 | 0.030 |
Why?
| | Amino Acyl-tRNA Synthetases | 1 | 2017 | 32 | 0.030 |
Why?
| | Iron-Sulfur Proteins | 1 | 2018 | 46 | 0.030 |
Why?
| | Qualitative Research | 1 | 2025 | 1734 | 0.030 |
Why?
| | Metabolomics | 1 | 2023 | 738 | 0.030 |
Why?
| | Neuroimaging | 1 | 2019 | 307 | 0.030 |
Why?
| | Severity of Illness Index | 1 | 2025 | 2921 | 0.030 |
Why?
| | Treatment Outcome | 2 | 2025 | 11821 | 0.030 |
Why?
| | Kinetics | 1 | 2020 | 1553 | 0.030 |
Why?
| | Genomics | 1 | 2022 | 853 | 0.030 |
Why?
| | Oxidation-Reduction | 1 | 2020 | 1075 | 0.030 |
Why?
| | Electroencephalography | 1 | 2019 | 576 | 0.030 |
Why?
| | Amino Acid Sequence | 1 | 2020 | 2092 | 0.030 |
Why?
| | Lipids | 1 | 2021 | 714 | 0.030 |
Why?
| | Glucose | 1 | 2021 | 1053 | 0.030 |
Why?
| | Neurons | 1 | 2024 | 1668 | 0.030 |
Why?
| | Family | 1 | 2020 | 690 | 0.030 |
Why?
| | Chromatin | 1 | 2019 | 559 | 0.030 |
Why?
| | Induced Pluripotent Stem Cells | 1 | 2018 | 269 | 0.030 |
Why?
| | Caregivers | 1 | 2023 | 1080 | 0.030 |
Why?
| | Child Development | 1 | 2019 | 481 | 0.030 |
Why?
| | Follow-Up Studies | 1 | 2024 | 5439 | 0.030 |
Why?
| | Oxygen Consumption | 1 | 2017 | 721 | 0.030 |
Why?
| | Saccharomyces cerevisiae Proteins | 1 | 2018 | 411 | 0.030 |
Why?
| | DNA Methylation | 1 | 2019 | 725 | 0.030 |
Why?
| | Mice | 2 | 2023 | 18297 | 0.020 |
Why?
| | Liver | 1 | 2022 | 1864 | 0.020 |
Why?
| | Saccharomyces cerevisiae | 1 | 2018 | 584 | 0.020 |
Why?
| | Muscle, Smooth | 1 | 2014 | 152 | 0.020 |
Why?
| | Prognosis | 1 | 2021 | 4351 | 0.020 |
Why?
| | Kidney Transplantation | 1 | 2018 | 735 | 0.020 |
Why?
| | Kidney | 1 | 2018 | 1498 | 0.020 |
Why?
| | Cells, Cultured | 1 | 2017 | 4118 | 0.020 |
Why?
| | Tomography, X-Ray Computed | 1 | 2020 | 2786 | 0.020 |
Why?
| | Obesity | 1 | 2021 | 3131 | 0.020 |
Why?
|
|
Larson's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts  Derived automatically from this person's publications. _
Co-Authors  People in Profiles who have published with this person. _
Similar People  People who share similar concepts with this person. _
Same Department
People who are also in this person's primary department.
Physical Neighbors  People whose addresses are nearby this person. _
|